Afuco™ Anti-Human GRN ADCC Therapeutic Antibody, ADCC Enhanced
Anti-GRN ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a neutralizing anti-GP88 antibody, inhibits GP88 biological effect (proliferation and migration) in a dose-dependent fashion in vitro, used for treating breast cancer.
Supplier | Creative Biolabs |
---|---|
Product # | AFC-319CL |
Pricing | Inquiry |
Host | Human |
Target | GRN |
Species Reactivity | Human |
Type | ADCC enhanced antibody |
Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |